Guyasuta Investment Advisors Inc. Decreases Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Guyasuta Investment Advisors Inc. cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.4% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 51,735 shares of the healthcare conglomerate’s stock after selling 185 shares during the period. UnitedHealth Group comprises about 1.8% of Guyasuta Investment Advisors Inc.’s holdings, making the stock its 17th largest position. Guyasuta Investment Advisors Inc.’s holdings in UnitedHealth Group were worth $27,237,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in UNH. Bell Investment Advisors Inc lifted its holdings in shares of UnitedHealth Group by 4.8% during the 4th quarter. Bell Investment Advisors Inc now owns 525 shares of the healthcare conglomerate’s stock worth $276,000 after acquiring an additional 24 shares during the period. Harbor Investment Advisory LLC lifted its holdings in shares of UnitedHealth Group by 3.2% during the 1st quarter. Harbor Investment Advisory LLC now owns 35,946 shares of the healthcare conglomerate’s stock worth $17,783,000 after acquiring an additional 1,129 shares during the period. Verdence Capital Advisors LLC lifted its holdings in shares of UnitedHealth Group by 2.1% during the 4th quarter. Verdence Capital Advisors LLC now owns 16,941 shares of the healthcare conglomerate’s stock worth $8,919,000 after acquiring an additional 342 shares during the period. Austin Private Wealth LLC lifted its holdings in shares of UnitedHealth Group by 9.8% during the 1st quarter. Austin Private Wealth LLC now owns 1,246 shares of the healthcare conglomerate’s stock worth $573,000 after acquiring an additional 111 shares during the period. Finally, Bellecapital International Ltd. lifted its holdings in shares of UnitedHealth Group by 1.4% during the 4th quarter. Bellecapital International Ltd. now owns 13,823 shares of the healthcare conglomerate’s stock worth $7,277,000 after acquiring an additional 193 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of analysts recently issued reports on the stock. Baird R W raised shares of UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Friday. Barclays increased their price objective on shares of UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. TD Cowen lowered their price objective on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research report on Wednesday, April 10th. Finally, Truist Financial reissued a “buy” rating and set a $600.00 price target on shares of UnitedHealth Group in a research report on Wednesday, April 17th. Three analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $579.74.

UnitedHealth Group Trading Up 4.8 %

Shares of UNH stock opened at $509.58 on Friday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.85 and a current ratio of 0.85. The firm has a market capitalization of $469.01 billion, a PE ratio of 31.15, a price-to-earnings-growth ratio of 1.41 and a beta of 0.58. The stock has a fifty day moving average of $498.34 and a two-hundred day moving average of $502.27. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating the consensus estimate of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. During the same period in the previous year, the firm earned $6.26 earnings per share. UnitedHealth Group’s quarterly revenue was up 8.6% on a year-over-year basis. As a group, research analysts expect that UnitedHealth Group Incorporated will post 27.57 EPS for the current year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were paid a dividend of $2.10 per share. This is an increase from UnitedHealth Group’s previous quarterly dividend of $1.88. The ex-dividend date of this dividend was Monday, June 17th. This represents a $8.40 annualized dividend and a yield of 1.65%. UnitedHealth Group’s dividend payout ratio is presently 51.34%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.